Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > Knowing What I Own
View:
Post by shaker13 on Feb 22, 2021 10:59am

Knowing What I Own

Lol DM still the most undervalued TSXV stock in Canada
Comparing to others often pumped here trading north of $2.00 with no HC approvals and no revenues
DM finally getting a little love
Think it's time I move my asks on my 7 digit holding up from $0.75 to $1.50
Still just the beginning here
GLTA
Comment by mrmonopoly on Feb 22, 2021 11:13am
Absolutely bump that up! CBDT is pulling a $700M+ market cap right now. They announced last week that their lab just passed 1000 tests per day.... DM was hitting that roughly a month and a half ago. Now we're at 1700 tests per day ish, maybe a bit more now as it seems to be increasing with every passing week. Know what you own...
Comment by subbzthehun on Feb 22, 2021 11:23am
Only difference is Empowers tests are run through their own clinic which they take the profits for. DM's just the middle man if I'm not mistaken, Empower definitely has the better margin.
Comment by shaker13 on Feb 22, 2021 11:30am
ScreenPro to start trading any day now, then the curtain will be lifted is my bet
Comment by TorlifTostorson on Feb 22, 2021 11:42am
@shaker: Do you have an idea if DM will own some shares of ScreenPro? Best Torlif  
Comment by shaker13 on Feb 22, 2021 11:49am
Torlif ...like I said , all will become apparent soon Any success ScreenPro receives will dovetail into success for DM Same for GBLC Same for TeleHealth Division which could be another spinout of its own like Ronin Blockchain Tons of value lies waiting for DM'ers
Comment by shaker13 on Feb 22, 2021 11:43am
There are no comparables to DM None This will become apparent to all in due course and why I am moving my asks up....just saying
Comment by TorlifTostorson on Feb 22, 2021 11:34am
@subbthethun: That's very likely. But DM has AI, Telehealth and Crypto too. Also they are active in Canada, USA, South Korea and Germany. But, congratulations to all CBDT investors, for their also great day. GLTA Torlif
Comment by subbzthehun on Feb 22, 2021 11:38am
Oh of course, I'm not even in empower, honestly their shareholders kind of anger me, they seem to have developed a little cult over there if you read their boards. If someone even happens to mention ANY other stock they get crucified lol.  IMO DM has more going on than empower, empowers just another clinic to me. DM really has to get on WSR now and it's game over. NEW INVESTORS EVEN ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities